Department of Neurological Surgery, University of California, San Francisco, California.
J Neurosurg Spine. 2013 Oct;19(4):471-6. doi: 10.3171/2013.6.SPINE12927. Epub 2013 Aug 23.
Myxopapillary ependymomas (MPEs) are rare WHO Grade I tumors found in the conus medullaris, cauda equina, and filum terminale. Treatment generally consists of resection with or without adjuvant radiotherapy. Evidence-based guidelines for surgical management are lacking due to the rarity of this tumor.
An English-language PubMed search was performed using the key words "myxopapillary" and "ependymoma." Reports describing fewer than 3 patients or those lacking data on the extent of resection or radiotherapy were excluded. A total of 28 articles describing 475 patients met the authors' inclusion criteria. Patients were grouped by extent of resection and whether or not they underwent adjuvant radiotherapy. Differences in recurrence rates were assessed by chi-square test.
The overall recurrence rate was 15.5% in patients treated by gross-total resection (GTR) and 32.6% in patients treated by subtotal resection (STR), irrespective of whether they underwent adjuvant therapy (p < 0.001). Regardless of the extent of resection, adjuvant radiotherapy was not associated with a decrease in recurrence rates. The overall recurrence rate was 15.6% in patients who underwent GTR and radiotherapy compared with 15.9% in patients who underwent GTR alone (p = 0.58), and it was 29.3% in patients who underwent STR and radiotherapy compared with 35.1% in those who underwent STR alone (p = 0.53). The difference between recurrence rates for patients who underwent GTR alone versus STR and radiotherapy was statistically significant (p = 0.02). Subgroup analysis demonstrated significantly higher recurrence rates in pediatric patients compared with adults (40.5% vs 23.4%, respectively; p = 0.02). Even in the setting of GTR alone, recurrence rates were higher in pediatric patients (65% vs 7.6%; p < 0.001).
Gross-total resection alone is associated with decreased recurrence rates compared with STR with or without radiotherapy. The authors' results suggest that treatment goals should include attempted GTR whenever possible. The observation that children benefitted from radiation therapy to a greater extent than did adults suggests that biological differences between tumors in these patient populations warrants more rigorous scientific studies.
髓内圆锥、马尾和终丝的罕见的 WHO 分级 I 肿瘤是粘液性乳头状室管膜瘤(MPE)。治疗通常包括切除,伴或不伴辅助放疗。由于这种肿瘤很少见,缺乏手术管理的循证指南。
使用关键词“粘液性乳头状”和“室管膜瘤”在英文的 PubMed 上进行了搜索。排除了描述少于 3 例患者或缺乏切除程度或放疗数据的报告。共有 28 篇描述了 475 例患者的文章符合作者的纳入标准。根据切除范围和是否接受辅助放疗将患者分组。通过卡方检验评估复发率的差异。
在接受大体全切除(GTR)的患者中,总体复发率为 15.5%,在接受次全切除(STR)的患者中,复发率为 32.6%,无论是否接受辅助治疗(p < 0.001)。无论切除范围如何,辅助放疗均与复发率降低无关。在接受 GTR 和放疗的患者中,总体复发率为 15.6%,而单独接受 GTR 的患者为 15.9%(p = 0.58),在接受 STR 和放疗的患者中,总体复发率为 29.3%,而单独接受 STR 的患者为 35.1%(p = 0.53)。单独接受 GTR 的患者与接受 STR 和放疗的患者之间的复发率差异具有统计学意义(p = 0.02)。亚组分析显示,儿科患者的复发率明显高于成人(分别为 40.5%和 23.4%,p = 0.02)。即使在单独 GTR 的情况下,儿科患者的复发率也更高(65%比 7.6%,p < 0.001)。
与 STR 伴或不伴放疗相比,单独进行大体全切除与降低复发率相关。作者的结果表明,只要有可能,治疗目标就应包括尝试 GTR。观察到儿童从放疗中获益的程度大于成人,这表明这些患者群体中肿瘤之间的生物学差异需要更严格的科学研究。